General Catalyst Group Management, LLC

13F filer · CIK 1637946 · Cambridge, MA

Summary

General Catalyst Group Management, LLC reported $188.52M across 14 positions in its 13F for 2026 Q2, filed Aug 17, 2026. The largest holdings are AVBP (27.5%), PBLS (23.2%), CART (17.9%). Versus 2026 Q1, leaving options aside, it opened 4 new positions, added to 3, trimmed 1 and sold out of 2.

Reported value$188.52M

Positions14

Report period2026 Q2

FiledAug 17, 2026

New positions4

Added3

Trimmed1

Sold out2

Top 14 holdings

By reported value, options listed separately · change vs 2026 Q1

AVBPArriVent BioPharma, Inc.Hold

Weight 27.5%Value $51.93MPrice $29.54Shares 1.49MSince Jun 30 -14.97%

PBLSParabilis Medicines, Inc.New

Weight 23.2%Value $43.82MPrice $31.91Shares 1.60MSince Jun 30 +16.59%

CARTMaplebear, Inc.Hold

Weight 17.9%Value $33.65MPrice $43.49Shares 711KSince Jun 30 -8.15%

MAZEMaze Therapeutics, Inc.Hold

Weight 16.4%Value $30.91MPrice $27.02Shares 1.04MSince Jun 30 -9.45%

ODTXOdyssey Therapeutics, Inc.New

Weight 8.0%Value $15.16MPrice $22.44Shares 810KSince Jun 30 +19.94%

EIKNEikon Therapeutics, Inc.Hold

Weight 2.1%Value $3.98MPrice $7.91Shares 305KSince Jun 30 -39.39%

GUTSFractyl Health, Inc.Trim

Weight 2.1%Value $3.88MPrice $0.52Shares 4.88M -0.00%Since Jun 30 -34.54%

LIFEEthos Technologies, Inc.Hold

Weight 0.7%Value $1.35MPrice $33.85Shares 74KSince Jun 30 +86.60%

CPNGCoupang Inc.Add

Weight 0.5%Value $949.7KPrice $13.85Shares 55K +49.08%Since Jun 30 -20.26%

AMZNAmazon.com Inc.Add

Weight 0.5%Value $925.2KPrice $246.67Shares 3,882 +50.35%Since Jun 30 +3.49%

METAMeta Platforms Inc.Add

Weight 0.4%Value $743.5KPrice $738.79Shares 1,320 +100.61%Since Jun 30 +31.16%

DASHDoordash Inc.New

Weight 0.3%Value $525.9KPrice $187.10Shares 2,850Since Jun 30 +1.39%

CVNACarvana CoNew

Weight 0.2%Value $425.5KPrice $63.62Shares 6,465Since Jun 30 -3.34%

FIGFigma, Inc.Hold

Weight 0.1%Value $268.5KPrice $20.72Shares 15KSince Jun 30 +14.54%

Stock	Weight	Value	Price	Shares	Since Jun 30	Shares change	Action
AVBPArriVent BioPharma, Inc.	27.5%	$51.93M	$29.54	1.49M	-14.97%	—	Hold
PBLSParabilis Medicines, Inc.	23.2%	$43.82M	$31.91	1.60M	+16.59%	—	New
CARTMaplebear, Inc.	17.9%	$33.65M	$43.49	711K	-8.15%	—	Hold
MAZEMaze Therapeutics, Inc.	16.4%	$30.91M	$27.02	1.04M	-9.45%	—	Hold
ODTXOdyssey Therapeutics, Inc.	8.0%	$15.16M	$22.44	810K	+19.94%	—	New
EIKNEikon Therapeutics, Inc.	2.1%	$3.98M	$7.91	305K	-39.39%	—	Hold
GUTSFractyl Health, Inc.	2.1%	$3.88M	$0.52	4.88M	-34.54%	-0.00%	Trim
LIFEEthos Technologies, Inc.	0.7%	$1.35M	$33.85	74K	+86.60%	—	Hold
CPNGCoupang Inc.	0.5%	$949.7K	$13.85	55K	-20.26%	+49.08%	Add
AMZNAmazon.com Inc.	0.5%	$925.2K	$246.67	3,882	+3.49%	+50.35%	Add
METAMeta Platforms Inc.	0.4%	$743.5K	$738.79	1,320	+31.16%	+100.61%	Add
DASHDoordash Inc.	0.3%	$525.9K	$187.10	2,850	+1.39%	—	New
CVNACarvana Co	0.2%	$425.5K	$63.62	6,465	-3.34%	—	New
FIGFigma, Inc.	0.1%	$268.5K	$20.72	15K	+14.54%	—	Hold

Weight is the share of the reported 13F value, including options at notional value. “Since Jun 30” compares the latest close with the quarter-end price implied by the filing (value ÷ shares).

Largest buys in 2026 Q2

PBLSParabilis Medicines, Inc.≈ $43.82MNew

ODTXOdyssey Therapeutics, Inc.≈ $15.16MNew

DASHDoordash Inc.≈ $525.9KNew

CVNACarvana Co≈ $425.5KNew

METAMeta Platforms Inc.≈ $372.9KAdd

Largest sells in 2026 Q2

IOTSAMSARA INC≈ $63.38MSold

GTLBGITLAB INC≈ $19.94MSold

GUTSFractyl Health, Inc.≈ $3Trim

Source: SEC Form 13F, values as reported by the filer. Filings lag up to 45 days after quarter end and cover only certain long positions. Research only, not investment advice.

Original filing All 13F filings on EDGAR